Angioplasty and Stenting for Atherosclerotic Intracranial Stenosis: Rationale for a Randomized Clinical Trial

Neuroimaging Clinics of North America

Volumn 17, Issue 3, 2007, Pages 355-363

  Derdeyn, Colin P ^a   Chimowitz, Marc I ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

ANGIOPLASTY; ATHEROSCLEROSIS; BARE METAL STENT; BLEEDING; BRAIN BLOOD FLOW; CLINICAL TRIAL; DRUG ELUTING STENT; HIGH RISK PATIENT; HUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RISK FACTOR; STENT; STROKE; SYMPTOM; TREATMENT INDICATION;

ANGIOPLASTY; ANTICOAGULANTS; BRAIN; CAROTID ARTERIES; CAROTID STENOSIS; CEREBRAL ARTERIES; CONSTRICTION, PATHOLOGIC; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STENTS;

EID: 34548443350     PISSN: 10525149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nic.2007.05.001     Document Type: Review

References (67)

1. Sacco R.L., Kargman D.E., Gu Q., et al. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. Stroke 26 (1995) 14-20
2. Wityk R.J., Lehman D., Klag M., et al. Race and sex differences in the distribution of cerebral atherosclerosis. Stroke 27 (1996) 1974-1980
3. Feldmann E., Daneault N., Kwan E., et al. Chinese-white differences in the distribution of occlusive cerebrovascular disease. Neurology 40 (1990) 1541-1545
4. Chimowitz M.I., Lynn M.J., Howlett-Smith H., et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 352 (2005) 1305-1316
5. Grubb Jr. R.L., Derdeyn C.P., Fritsch S.M., et al. Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. JAMA 280 (1998) 1055-1060
6. Caplan L.R., and Hennerici M. Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch Neurol 55 (1998) 1475-1482
7. Kasner S.E., Chimowitz M.I., Lynn M.J., et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 113 (2006) 555-563
8. Kasner S.E., Lynn M.J., Chimowitz M.I., et al. Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID. Neurology 67 (2006) 1275-1278
9. Benesch C.G., and Chimowitz M.I. Best treatment for intracranial arterial stenosis? 50 years of uncertainty. The WASID investigators. Neurology 55 (2000) 465-466
10. Broderick J., Brott T., Kothari R., et al. The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks. Stroke 29 (1998) 415-421
11. Executive Committee of the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 273 (1995) 1421-1428
12. Hart R.G., and Halperin J.L. Atrial fibrillation and thromboembolism: a decade of progress in stroke prevention. Ann Intern Med 131 (1999) 688-695
13. Derdeyn C.P., Powers W.J., and Grubb Jr. R.L. Hemodynamic effects of middle cerebral artery stenosis and occlusion. AJNR Am J Neuroradiol 19 (1998) 1463-1469
14. Yamauchi H., Fukuyama H., Nagahama Y., et al. Significance of increased oxygen extraction fraction in five-year prognosis of major cerebral arterial occlusive disease. J Nucl Med 40 (1999) 1992-1998
15. Lee D.K., Kim J.S., Kwon S.U., et al. Lesion patterns and stroke mechanism in atherosclerotic middle cerebral artery disease: early diffusion-weighted imaging study. Stroke 36 (2005) 2583-2588
16. Amin-Hanjani S., Du X., Zhao M., et al. Use of quantitative magnetic resonance angiography to stratify stroke risk in symptomatic vertebrobasilar disease. Stroke 36 (2005) 1140-1145
17. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 325 (1991) 445-453
18. The EC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke: Results of an international randomized trial. N Engl J Med 313 (1985) 1191-2000
19. Samuels O.B., Joseph G.J., Lynn M.J., et al. A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol 21 (2000) 643-646
20. Chimowitz M.I., Kokkinos J., Strong J., et al. The warfarin-aspirin symptomatic intracranial disease study. Neurology 45 (1995) 1488-1493
21. The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) study group. Prognosis of patients with symptomatic vertebral or basilar artery stenosis. Stroke 29 (1998) 1389-1392
22. Thijs V.N., and Albers G.W. Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Neurology 55 (2000) 490-497
23. Chobanian A.V., Bakris G.L., Black H.R., et al. The seventh report of the Joint National Committee On Prevention, Detection, Evaluation, And Treatment of High Blood Pressure: the JNC 7 report. JAMA 289 (2003) 2560-2572
24. Grundy S.M., Cleeman J.I., Merz C.N., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110 (2004) 227-239
25. Standards of medical care in diabetes-2006. Diabetes Care 29 Suppl 1 (2006) S4-S42
26. Circulation in press.
27. Turan TN, Cotsonis GA, Lynn MJ, et al. Risk factors associated with recurrent ischemic stroke in patients with symptomatic intracranial stenosis. Presented at the Joint World Congress of Stroke. Cape Town, South Africa, October 27, 2006.
28. Amarenco P., Bogousslavsky J., Callahan III A., et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 355 (2006) 549-559
29. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 358 (2001) 1033-1041
30. Sacks F.M., Pfeffer M.A., Moye L.A., et al., for the Cholesterol and Recurrent Events Trial Investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 335 (1996) 1001-1009
31. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary artery disease. The Scandinavian Simvastatin Survival Study (4S). Lancet 344 (1994) 1383-1389
32. Pitt B., Waters D., Brown W.V., et al., Atorvastatin versus revascularization treatment investigators. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. N Engl J Med 341 (1999) 70-76
33. Boden W.E., O'Rourke R.A., Teo K.K., et al., the CTRG. Optimal medical therapy with or without pci for stable coronary disease. N Engl J Med 356 15 (2007) 1503-1516
34. Diener P.H.-C., Bogousslavsky P.J., Brass P.L.M., et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (match): randomised, double-blind, placebo-controlled trial. Lancet 364 (2004) 331-337
35. Diener H.C., Cunha L., Forbes C., et al. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 143 (1996) 1-13
36. ESPRIT Study Group: Halkes PH, van Gijn J, Kappelle LJ, et al. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (esprit): randomised controlled trial. Lancet 367:1665-73.
37. Sundt Jr. T.M., Smith H.C., Campbell J.K., et al. Transluminal angioplasty for basilar artery stenosis. Mayo Clin Proc 55 (1980) 673-680
38. Higashida R.T., Tsai F.Y., Halbach V.V., et al. Transluminal angioplasty for atherosclerotic disease of the vertebral and basilar arteries. J Neurosurg 78 (1993) 192-198
39. Clark W.M., Barnwell S.L., Nesbit G., et al. Safety and efficacy of percutaneous transluminal angioplasty for intracranial atherosclerotic stenosis. Stroke 26 (1995) 1200-1204
40. Tuoho H. Percutaneous transluminal angioplasty in the treatment of atherosclerotic disease in the anterior circulation and hemodynamic evaluation. J Neurosurg 82 (1995) 953-960
41. Takis C., Kwan E.S., Pessin M.S., et al. Intracranial angioplasty: experience and complications. AJNR Am J Neuroradiol 18 (1997) 1661-1668
42. Marks M.P., Marcellus M., Norbash A.M., et al. Outcome of angioplasty for atherosclerotic intracranial stenosis. Stroke 30 (1999) 1065-1069
43. Marks M.P., Wojak J.C., Al-Ali F., et al. Angioplasty for symptomatic intracranial stenosis: clinical outcome. Stroke 37 (2006) 1016-1020
44. Connors III J.J., and Wojak J.C. Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: evolution of technique and short-term results. J Neurosurg 91 (1999) 415-423
45. Alazzaz A., Thornton J., Aletich V.A., et al. Intracranial percutaneous transluminal angioplasty for arteriosclerotic stenosis. Arch Neurol 57 (2000) 1625-1630
46. Nahser H.C., Henkes H., Weber W., et al. Intracranial vertebrobasilar stenosis: angioplasty and follow-up. AJNR Am J Neuroradiol 21 (2000) 1293-1301
47. Gress D.R., Smith W.S., Dowd C.F., et al. Angioplasty for intracranial symptomatic vertebrobasilar ischemia. Neurosurgery 51 (2002) 23-27 [discussion: 27-9]
48. Gupta R., Schumacher H.C., Mangla S., et al. Urgent endovascular revascularization for symptomatic intracranial atherosclerotic stenosis. Neurology 61 (2003) 1729-1735
49. Gomez C.R., Misra V.K., Campbell M.S., et al. Elective stenting of symptomatic middle cerebral artery stenosis. AJNR Am J Neuroradiol 21 (2000) 971-973
50. Gomez C.R., Misra V.K., Liu M.W., et al. Elective stenting of symptomatic basilar artery stenosis. Stroke 31 (2000) 95-99
51. Rasmussen P.A., Perl II J., Barr J.D., et al. Stent-assisted angioplasty of intracranial vertebrobasilar atherosclerosis: an initial experience. J Neurosurg 92 (2000) 771-778
52. Levy E.I., Hanel R.A., Boulos A.S., et al. Comparison of periprocedure complications resulting from direct stent placement compared with those due to conventional and staged stent placement in the basilar artery. J Neurosurg 99 (2003) 653-660
53. Kim D.J., Lee B.H., Kim D.I., et al. Stent-assisted angioplasty of symptomatic intracranial vertebrobasilar artery stenosis: feasibility and follow-up results. AJNR Am J Neuroradiol 26 (2005) 1381-1388
54. de Rochemont M., Turowski B., Buchkremer M., et al. Recurrent symptomatic high-grade intracranial stenoses: safety and efficacy of undersized stents-initial experience. Radiology 231 (2004) 45-49
55. Liu J.M., Hong B., Huang Q.H., et al. [Safety and short-term results of stent-assisted angioplasty for the treatment of intracranial arterial stenosis]. Zhonghua Wai Ke Za Zhi 42 (2004) 169-172 [in Chinese]
56. Zhang Q.Z., Miao Z.R., Li S.M., et al. [Complications of stent-assistant angioplasty of symptomatic intracranial artery stenosis]. Zhonghua Yi Xue Za Zhi 83 (2003) 1402-1405 [in Chinese]
57. Jiang W.J., Du B., Wang Y.J., et al. [Symptomatic intracranial artery stenosis: angiographic classifications and stent-assisted angioplasty]. Zhonghua Nei Ke Za Zhi 42 (2003) 545-549 [in Chinese]
58. Jiang W.J., Wang Y.J., Du B., et al. Stenting of symptomatic m1 stenosis of middle cerebral artery: an initial experience of 40 patients. Stroke 35 (2004) 1375-1380
59. Lylyk P., Vila J.F., Miranda C., et al. Endovascular reconstruction by means of stent placement in symptomatic intracranial atherosclerotic stenosis. Neurol Res 27 Suppl 1 (2005) S84-S88
60. SSYLVIA Study Investigators. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 35 (2004) 1388-1392
61. Jiang W.J., Xu X.T., Du B., et al. Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenosis. Neurology 68 (2007) 420-426
62. Gupta R., Al-Ali F., Thomas A.J., et al. Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation. Stroke 37 (2006) 2562-2566
63. Abou-Chebl A., Bashir Q., and Yadav J.S. Drug-eluting stents for the treatment of intracranial atherosclerosis: initial experience and midterm angiographic follow-up. Stroke 36 (2005) e165-e168
64. Iakovou I., Schmidt T., Bonizzoni E., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
65. Hartmann M, Bose A, Henkes H, et al. One year stroke risks in high grade, symptomatic, medically refractory intracranial atherosclerosis after angioplasty and stenting: the Wingspan trial. Presented at the International Stroke Conference. Kissimmee (FL), February 18, 2006.
66. Fiorella D., Levy E.I., Turk A.S., et al. US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke 38 (2007) 881-887
67. Henkes H., Miloslavski E., Lowens S., et al. Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (Wingspan). Neuroradiology 47 (2005) 222-228